Exact Mass: 481.198
Exact Mass Matches: 481.198
Found 500 metabolites which its exact mass value is equals to given mass value 481.198
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Pranlukast
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DC - Leukotriene receptor antagonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D020024 - Leukotriene Antagonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent
Pranlukast
Pranlukast is only found in individuals that have used or taken this drug. It is a cysteinyl leukotriene receptor-1 antagonist. It antagonizes or reduces bronchospasm caused, principally in asthmatics, by an allergic reaction to accidentally or inadvertently encountered allergens.Pranlukast selectively antagonizes leukotriene D4 (LTD4) at the cysteinyl leukotriene receptor, CysLT1, in the human airway. Pranlukast inhibits the actions of LTD4 at the CysLT1 receptor, preventing airway edema, smooth muscle contraction, and enhanced secretion of thick, viscous mucus.
Acebilustat
Stallimycin
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D004214 - Distamycins D000890 - Anti-Infective Agents > D000998 - Antiviral Agents
gamma-Glutamyl-N'-(2-hydroxyphenyl)hydrazide
1,3-Dithiane-2-propanamine, N-(2-(3,4-dimethoxyphenyl)ethyl)-N-methyl-2-(2-naphthalenyl)-
(3S)-3-[[(2S)-2-[[(2S)-2-Amino-3-methylbutanoyl]amino]propanoyl]-phenylmethoxycarbonylamino]-6-fluoro-4,5-dioxohexanoic acid
Benzyloxycarbonylvalyl-alanyl-aspartyl Fluoromethyl Ketone
6beta-benzoyloxy-3alpha-(E)-(3,4,5-trimethoxycinnamoyloxy)tropane
Ala Asp Asn Tyr
Ala Asp Tyr Asn
Ala Phe Met Asn
Ala Phe Asn Met
Ala Met Phe Asn
Ala Met Asn Phe
Ala Asn Asp Tyr
Ala Asn Phe Met
Ala Asn Met Phe
Ala Asn Tyr Asp
Ala Gln Thr Tyr
Ala Gln Tyr Thr
Ala Thr Gln Tyr
Ala Thr Tyr Gln
Ala Tyr Asp Asn
Ala Tyr Asn Asp
Ala Tyr Gln Thr
Ala Tyr Thr Gln
Cys Cys Arg Thr
Cys Cys Thr Arg
Cys Phe Gly Arg
Cys Phe Asn Val
Cys Phe Arg Gly
Cys Phe Val Asn
Cys Gly Phe Arg
Cys Gly Arg Phe
Cys Lys Met Thr
Cys Lys Thr Met
Cys Met Lys Thr
Cys Met Thr Lys
Cys Asn Phe Val
Cys Asn Val Phe
Cys Arg Cys Thr
Cys Arg Phe Gly
Cys Arg Gly Phe
Cys Arg Thr Cys
Cys Thr Cys Arg
Cys Thr Lys Met
Cys Thr Met Lys
Cys Thr Arg Cys
Cys Val Phe Asn
Cys Val Asn Phe
Asp Ala Asn Tyr
Asp Ala Tyr Asn
Asp Phe Asn Ser
Asp Phe Ser Asn
Asp Gly Lys Tyr
Asp Gly Gln Tyr
Asp Gly Tyr Lys
Asp Gly Tyr Gln
Asp His Asn Pro
Asp His Pro Asn
Asp Lys Gly Tyr
Asp Lys Tyr Gly
Asp Asn Ala Tyr
Asp Asn Phe Ser
Asp Asn His Pro
Asp Asn Pro His
Asp Asn Ser Phe
Asp Asn Tyr Ala
Asp Pro His Asn
Asp Pro Asn His
Asp Gln Gly Tyr
Asp Gln Tyr Gly
Asp Ser Phe Asn
Asp Ser Asn Phe
Asp Tyr Ala Asn
Asp Tyr Gly Lys
Asp Tyr Gly Gln
Asp Tyr Lys Gly
Asp Tyr Asn Ala
Asp Tyr Gln Gly
Glu Gly Asn Tyr
Glu Gly Tyr Asn
Glu Asn Gly Tyr
Glu Asn Tyr Gly
Glu Tyr Gly Asn
Glu Tyr Asn Gly
Phe Ala Met Asn
Phe Ala Asn Met
Phe Cys Gly Arg
Phe Cys Asn Val
Phe Cys Arg Gly
Phe Cys Val Asn
Phe Asp Asn Ser
Phe Asp Ser Asn
Phe Gly Cys Arg
Phe Gly Met Gln
Phe Gly Gln Met
Phe Gly Arg Cys
Phe Met Ala Asn
Phe Met Gly Gln
Phe Met Asn Ala
Phe Met Gln Gly
Phe Asn Ala Met
Phe Asn Cys Val
Phe Asn Asp Ser
Phe Asn Met Ala
Phe Asn Ser Asp
Phe Asn Thr Thr
Phe Asn Val Cys
Phe Gln Gly Met
Phe Gln Met Gly
Phe Gln Ser Thr
Phe Gln Thr Ser
Phe Arg Cys Gly
Phe Arg Gly Cys
Phe Ser Asp Asn
Phe Ser Asn Asp
Phe Ser Gln Thr
Phe Ser Thr Gln
Phe Thr Asn Thr
Phe Thr Gln Ser
Phe Thr Ser Gln
Phe Thr Thr Asn
Phe Val Cys Asn
Phe Val Asn Cys
Gly Cys Phe Arg
Gly Cys Arg Phe
Gly Asp Lys Tyr
Gly Asp Gln Tyr
Gly Asp Tyr Lys
Gly Asp Tyr Gln
Gly Glu Asn Tyr
Gly Glu Tyr Asn
Gly Phe Cys Arg
Gly Phe Met Gln
Gly Phe Gln Met
Gly Phe Arg Cys
Gly Gly Trp Tyr
Gly Gly Tyr Trp
Gly Lys Asp Tyr
Gly Lys Tyr Asp
Gly Met Phe Gln
Gly Met Gln Phe
Gly Asn Glu Tyr
Gly Asn Tyr Glu
Gly Gln Asp Tyr
Gly Gln Phe Met
Gly Gln Met Phe
Gly Gln Tyr Asp
Gly Arg Cys Phe
Gly Arg Phe Cys
Gly Trp Gly Tyr
Gly Trp Tyr Gly
Gly Tyr Asp Lys
Gly Tyr Asp Gln
Gly Tyr Glu Asn
Gly Tyr Gly Trp
Gly Tyr Lys Asp
Gly Tyr Asn Glu
Gly Tyr Gln Asp
Gly Tyr Trp Gly
His Asp Asn Pro
His Asp Pro Asn
His Asn Asp Pro
His Asn Pro Asp
His Pro Asp Asn
His Pro Asn Asp
Lys Cys Met Thr
Lys Cys Thr Met
Lys Asp Gly Tyr
Lys Asp Tyr Gly
Lys Gly Asp Tyr
Lys Gly Tyr Asp
Lys Met Cys Thr
Lys Met Thr Cys
Lys Thr Cys Met
Lys Thr Met Cys
Lys Tyr Asp Gly
Lys Tyr Gly Asp
Met Ala Phe Asn
Met Ala Asn Phe
Met Cys Lys Thr
Met Cys Thr Lys
Met Phe Ala Asn
Met Phe Gly Gln
Met Phe Asn Ala
Met Phe Gln Gly
Met Gly Phe Gln
Met Gly Gln Phe
Met Lys Cys Thr
Met Lys Thr Cys
Met Asn Ala Phe
Met Asn Phe Ala
Met Gln Phe Gly
Met Gln Gly Phe
Met Thr Cys Lys
Met Thr Lys Cys
Asn Ala Asp Tyr
Asn Ala Phe Met
Asn Ala Met Phe
Asn Ala Tyr Asp
Asn Cys Phe Val
Asn Cys Val Phe
Asn Asp Ala Tyr
Asn Asp Phe Ser
Asn Asp His Pro
Asn Asp Pro His
Asn Asp Ser Phe
Asn Asp Tyr Ala
Asn Glu Gly Tyr
Asn Glu Tyr Gly
Asn Phe Ala Met
Asn Phe Cys Val
Asn Phe Asp Ser
Asn Phe Met Ala
Asn Phe Ser Asp
Asn Phe Thr Thr
Asn Phe Val Cys
Asn Gly Glu Tyr
Asn Gly Tyr Glu
Asn His Asp Pro
Asn His Pro Asp
Asn Met Ala Phe
Asn Met Phe Ala
Asn Pro Asp His
Asn Pro His Asp
Asn Ser Asp Phe
Asn Ser Phe Asp
Asn Ser Val Tyr
Asn Ser Tyr Val
Asn Thr Phe Thr
Asn Thr Thr Phe
Asn Val Cys Phe
Asn Val Phe Cys
Asn Val Ser Tyr
Asn Val Tyr Ser
Asn Tyr Ala Asp
Asn Tyr Asp Ala
Asn Tyr Glu Gly
Asn Tyr Gly Glu
Asn Tyr Ser Val
Asn Tyr Val Ser
Pro Asp His Asn
Pro Asp Asn His
Pro His Asp Asn
Pro His Asn Asp
Pro Asn Asp His
Pro Asn His Asp
Gln Ala Thr Tyr
Gln Ala Tyr Thr
Gln Asp Gly Tyr
Gln Asp Tyr Gly
Gln Phe Gly Met
Gln Phe Met Gly
Gln Phe Ser Thr
Gln Phe Thr Ser
Gln Gly Asp Tyr
Gln Gly Phe Met
Gln Gly Met Phe
Gln Gly Tyr Asp
Gln Met Phe Gly
Gln Met Gly Phe
Gln Ser Phe Thr
Gln Ser Thr Phe
Gln Thr Ala Tyr
Gln Thr Phe Ser
Gln Thr Ser Phe
Gln Thr Tyr Ala
Gln Tyr Ala Thr
Gln Tyr Asp Gly
Gln Tyr Gly Asp
Gln Tyr Thr Ala
Arg Cys Cys Thr
Arg Cys Phe Gly
Arg Cys Gly Phe
Arg Cys Thr Cys
Arg Phe Cys Gly
Arg Phe Gly Cys
Arg Gly Cys Phe
Arg Gly Phe Cys
Arg Thr Cys Cys
Ser Asp Phe Asn
Ser Asp Asn Phe
Ser Phe Asp Asn
Ser Phe Asn Asp
Ser Phe Gln Thr
Ser Phe Thr Gln
Ser Asn Asp Phe
Ser Asn Phe Asp
Ser Asn Val Tyr
Ser Asn Tyr Val
Ser Gln Phe Thr
Ser Gln Thr Phe
Ser Thr Phe Gln
Ser Thr Gln Phe
Ser Val Asn Tyr
Ser Val Tyr Asn
Ser Tyr Asn Val
Ser Tyr Val Asn
Thr Ala Gln Tyr
Thr Ala Tyr Gln
Thr Cys Cys Arg
Thr Cys Lys Met
Thr Cys Met Lys
Thr Cys Arg Cys
Thr Phe Asn Thr
Thr Phe Gln Ser
Thr Phe Ser Gln
Thr Phe Thr Asn
Thr Lys Cys Met
Thr Lys Met Cys
Thr Met Cys Lys
Thr Met Lys Cys
Thr Asn Phe Thr
Thr Asn Thr Phe
Thr Gln Ala Tyr
Thr Gln Phe Ser
Thr Gln Ser Phe
Thr Gln Tyr Ala
Thr Arg Cys Cys
Thr Ser Phe Gln
Thr Ser Gln Phe
Thr Thr Phe Asn
Thr Thr Asn Phe
Thr Tyr Ala Gln
Thr Tyr Gln Ala
Val Cys Phe Asn
Val Cys Asn Phe
Val Phe Cys Asn
Val Phe Asn Cys
Val Asn Cys Phe
Val Asn Phe Cys
Val Asn Ser Tyr
Val Asn Tyr Ser
Val Ser Asn Tyr
Val Ser Tyr Asn
Val Tyr Asn Ser
Val Tyr Ser Asn
Trp Gly Gly Tyr
Trp Gly Tyr Gly
Trp Tyr Gly Gly
Tyr Ala Asp Asn
Tyr Ala Asn Asp
Tyr Ala Gln Thr
Tyr Ala Thr Gln
Tyr Asp Ala Asn
Tyr Asp Gly Lys
Tyr Asp Gly Gln
Tyr Asp Lys Gly
Tyr Asp Asn Ala
Tyr Asp Gln Gly
Tyr Glu Gly Asn
Tyr Glu Asn Gly
Tyr Gly Asp Lys
Tyr Gly Asp Gln
Tyr Gly Glu Asn
Tyr Gly Gly Trp
Tyr Gly Lys Asp
Tyr Gly Asn Glu
Tyr Gly Gln Asp
Tyr Gly Trp Gly
Tyr Lys Asp Gly
Tyr Lys Gly Asp
Tyr Asn Ala Asp
Tyr Asn Asp Ala
Tyr Asn Glu Gly
Tyr Asn Gly Glu
Tyr Asn Ser Val
Tyr Asn Val Ser
Tyr Gln Ala Thr
Tyr Gln Asp Gly
Tyr Gln Gly Asp
Tyr Gln Thr Ala
Tyr Ser Asn Val
Tyr Ser Val Asn
Tyr Thr Ala Gln
Tyr Thr Gln Ala
Tyr Val Asn Ser
Tyr Val Ser Asn
Tyr Trp Gly Gly
3-Ethyl-5-methyl-4-(2-chlorophenyl)-2-(2,2-diethoxy-ethoxymethyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
Acebilustat
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C308 - Immunotherapeutic Agent > C574 - Immunosuppressant Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
diethyl 2,6-bis((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
1,3-Dithiane-2-propanamine, N-(2-(3,4-dimethoxyphenyl)ethyl)-N-methyl-2-(2-naphthalenyl)-
1-[2-(3-Biphenyl)-4-methylvaleryl)]amino-3-(2-pyridylsulfonyl)amino-2-propanone
[3-(Hydroxymethyl)-1-{[4-({1-[5-(4-methoxyphenyl)-1,3,4-oxadiazole-2-carbonyl]azetidin-3-yl}oxy)phenyl]methyl}azetidin-3-yl]methanol
Cbz-DL-Val-DL-Ala-DL-Asp-AcF
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors D009676 - Noxae > D000477 - Alkylating Agents > D000590 - Amino Acid Chloromethyl Ketones D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D020011 - Protective Agents
(3S)-3-[[(2S)-2-[[(2S)-2-Amino-3-methylbutanoyl]amino]propanoyl]-phenylmethoxycarbonylamino]-6-fluoro-4,5-dioxohexanoic acid
[2-[2-[[2-[(4-Amino-4-carboxybutanoyl)amino]-3-(hydroxymethylsulfanyl)propanoyl]amino]acetyl]oxy-3-carboxypropyl]-trimethylazanium
Arg-Thr-Cys-Cys
A tetrapeptide composed of L-arginine, L-threonine and two L-cysteine units joined in sequence by peptide linkages.